title: Severe opioid withdrawal syndrome after a single dose of nalmefene.
authors.affiliation: Department of Anaesthesiology, Kantonsspital Baselland, Liestal, Switzerland.
authors.forename: Nadine
authors.initials: N
authors.lastname: Donnerstag
authors.forename: Tobias
authors.initials: T
authors.lastname: Schneider
authors.forename: Adrian
authors.initials: A
authors.lastname: Lüthi
authors.forename: Anne
authors.initials: A
authors.lastname: Taegtmeyer
authors.forename: Alexandra
authors.initials: A
authors.lastname: Raetz Bravo
authors.forename: Annekathrin
authors.initials: A
authors.lastname: Mehlig
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000188:drug therapy; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003061:Codeine / Q000008:administration & dosage / Q000009:adverse effects; D000075202:Contraindications; D004347:Drug Interactions; D006801:Humans; D008297:Male; D008691:Methadone / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D009271:Naltrexone / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D058850:Opiate Substitution Treatment; D009293:Opioid-Related Disorders; D013375:Substance Withdrawal Syndrome / Q000209:etiology*
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009271:Naltrexone; C038981:nalmefene; D008691:Methadone; D003061:Codeine